Hathaway Russell

Hathaway Russell is an IP lawyer with over 24 years of experience, specialising in the life sciences sector. She provides legal counsel to pharmaceutical clients including AbbVie, Pharmacyclics, and Allergan, biopharmaceutical corporations such as Biodesix, and academic institutions including Johns Hopkins University.Russell delivers worldwide patent portfolio management, competitive landscape analyses, freedom-to-operate assessments, and patent due diligence, as well as resolving inventorship disputes. Her expertise covers immunology, biochemistry, pharmacogenomics, proteomics, and disease biomarkers, supporting the protection of drug products and personalised medicine applications.Additionally, she develops global patent strategies for multi-billion-dollar drug products, conducting IP due diligence for major transactions, and collaborating with her firm’s healthcare department on US Food and Drug Administration (FDA) regulatory initiatives, particularly in advanced diagnostics. Hathaway has filed amicus briefs in Supreme Court cases concerning personalised medicine.As managing partner and executive committee member at her firm, Russell contributes to strategic growth and mentors women in the field. She serves in leadership positions within AIPLA, including as chair of the Women in IP Committee, vice-chair of the Education Committee, and chair of the Biotechnology Committee’s Legislative Policy Subcommittee.Her client work includes securing IP rights for products such as Humira, Botox, and Venclexa. Russell’s practice encompasses patent prosecution, enforcement strategies, and management of immunotherapeutic manufacturing and next-generation therapeutic antibody technologies.